[1]李 想,孙春雷,张 懿,等.无充气腋窝入路腔镜手术治疗甲状腺乳头状癌的疗效研究[J].医学信息,2021,34(04):115-118.[doi:10.3969/j.issn.1006-1959.2021.04.030]
　LI Xiang,SUN Chun-lei,ZHANG Yi,et al.Study on the Curative Effect of Laparoscopic Surgery Non-inflated Axillary Approach in the Treatment of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(04):115-118.[doi:10.3969/j.issn.1006-1959.2021.04.030]
点击复制

无充气腋窝入路腔镜手术治疗甲状腺乳头状癌的疗效研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年04期
页码:
115-118
栏目:
论著
出版日期:
2021-02-15

文章信息/Info

Title:
Study on the Curative Effect of Laparoscopic Surgery Non-inflated Axillary Approach in the Treatment of Papillary Thyroid Carcinoma
文章编号:
1006-1959（2021）04-0115-04
作者:
李 想; 孙春雷; 张 懿; 等
（安徽医科大学附属省立医院普外科，安徽 合肥 230001）
Author(s):
LI Xiang; SUN Chun-lei; ZHANG Yi; et al.
(General Surgery,Provincial Hospital Affiliated to Anhui Medical University,Hefei 230001,Anhui,China)
关键词:
甲状腺乳头状癌; 无充气腋窝入路 ; 甲状腺切除术; 美容满意度
Keywords:
Papillary thyroid carcinoma; Non-inflated axillary approach; Thyroidectomy; Cosmetic satisfaction
分类号:
R653
DOI:
10.3969/j.issn.1006-1959.2021.04.030
文献标志码:
A
摘要:
目的 探讨无充气腋窝入路腔镜手术与颈部开放手术治疗单侧甲状腺乳头状癌的疗效。方法 选取2019年6月~2020年7月于安徽医科大学附属省立医院接受手术治疗的181例甲状腺癌患者，其中85例行无充气腋窝入路腔镜甲状腺癌根治术设为腔镜组，96例行颈前切口甲状腺癌根治术设为开放组，比较两组手术指标、术后第1天、第2天及术后总引流量、拔管时间、术后住院时间、住院费用、术后并发症及术后疼痛VAS评分。结果 两组年龄、甲状腺大小、肿瘤直径、中央区清扫淋巴结数目及阳性数目、术中出血量、术后拔管时间及术后住院时间比较，差异无统计学意义（P＞0.05）；腔镜组手术时间、术后第1天、第2天及术后总引流液量、住院费用与开放组比较，差异有统计学意义（P＜0.01）；腔镜组手术时间与临床病理因素无显著相关（P＞0.05）；两组术后并发症除颈部不适外比较，差异无统计学意义（P＞0.05）；两组手术当天、术后第1、2天疼痛评分比较，差异无统计学意义（P＞0.05）；腔镜组美容满意度高于开放组，差异有统计学意义（P＜0.05）。结论 无充气腋窝入路腔镜甲状腺手术治疗甲状腺癌是可行的，能降低患者术后颈部不适感，且手术创伤小、美容效果更佳，可考虑作为单侧甲状腺乳头状患者的首选治疗方式。
Abstract:
Objective To explore the curative effect of non-inflated axillary approach laparoscopic surgery and open neck surgery for unilateral papillary thyroid carcinoma.Methods A total of 181 patients with thyroid cancer who underwent surgical treatment at the Provincial Hospital Affiliated to Anhui Medical University from June 2019 to July 2020 were selected. Among them, 85 patients underwent laparoscopic radical thyroid cancer resection non-inflated axillary approach were selected as the endoscopic group.96 patients undergoing anterior neck incision radical resection of thyroid cancer were set as the open group. The surgical indicators, the first day, the second day after the operation and the total drainage, the extubation time, the postoperative hospital stay, the hospitalization cost, and the operation VAS score for post-complication and postoperative pain.Results There were no statistically significant differences between the two groups in age, thyroid size, tumor diameter, central area dissection lymph node number and positive number, intraoperative blood loss, postoperative extubation time and postoperative hospital stay (P＞0.05);Compared with the open group, the operation time, the first day, the second day and the total amount of drainage fluid, and hospitalization expenses in the laparoscopy group were statistically significant (P＜0.01);There was no significant correlation between operation time and clinicopathological factors in the endoscopy group (P＞0.05);There was no significant difference in postoperative complications between the two groups except for neck discomfort (P＞0.05);There was no statistically significant difference in pain scores between the two groups on the day of surgery, the first and second days after surgery (P＞0.05);The cosmetic satisfaction degree of the endoscopy group was higher than that of the open group,the difference was statistically significant (P＜0.05).Conclusion Endoscopic thyroid surgery non-inflated axillary approach is feasible for the treatment of thyroid cancer. It can reduce postoperative neck discomfort, and has less trauma and better cosmetic effects. It can be considered as the first choice for patients with unilateral papillary thyroid.

参考文献/References:

[1]董芬,张彪,单广良.中国甲状腺癌的流行现状和影响因素[J].中国癌症杂志,2016,26(1):47-52. [2]孙厚权,孙书凝,甘芠源.不同手术方式治疗分化型甲状腺癌的临床效果及价值体会[J].中国实用医药,2020,15(26):80-82. [3]丁科,黄江生,汪明明,等.腔镜与开放手术治疗低危型甲状腺乳头状癌的疗效比较:附538例报告[J].中国普通外科杂志,2019,28(5):524-531. [4]王宇,史荣亮,孙团起,等.腔镜技术在甲状腺手术中的应用选择[J].中国普通外科杂志,2018,27(5):531-534. [5]陶崇翥,陈卫华,刘彦.全乳晕入路腔镜甲状腺微小乳头状癌根治术:附23例报告[J].中国普通外科杂志,2017,26(11):1392-1396. [6]Haugen BR,Alexander EK,Bible KC,et al.2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J].Thyroid,2016,26(1):1-133. [7]李红强,殷德涛,马润声,等.腔镜与开放术式在甲状腺微小乳头状癌外科治疗中的疗效比较[J].西安交通大学学报(医学版),2018,39(1):5-8. [8]孙辉,田文.甲状腺及甲状旁腺术中喉上神经外支保护与监测专家共识(2017版)[J].中国实用外科杂志,2017,37(11):1243-1249. [9]刘溦薇,周鸣,赵吉,等.腔镜甲状腺手术与传统甲状腺手术后的并发症比较[J].中国普外基础与临床杂志,2018,25(3):323-327. [10]Zhou Z,Liang F,Yu S,et al.The effect of preservation of the supraclavicular nerve on sensation recovery in endoscopic thyroidectomy via a gasless anterior chest approach:A prospective study[J].Surgeon,2020(20):30054-30058. [11]李力波,陈新岐,蔡永昌,等.腔镜与开放手术治疗低危甲状腺乳头状癌的临床分析[J].中国肿瘤外科杂志,2017,9(3):174-176. [12]王存川,李诚.腔镜甲状腺手术入路与适应证的进展[J].腹腔镜外科杂志,2016,21(4):241-245.

相似文献/References:

[1]郑时玉,郭亚男.c-Met及MACC1在甲状腺乳头状癌中的表达及临床意义[J].医学信息,2022,35(15):36.[doi:10.3969/j.issn.1006-1959.2022.15.007]
　ZHENG Shi-yu,GUO Ya-nan.Expression and Clinical Significance of c-Met and MACC1 in Papillary Thyroid Carcinoma[J].Medical Information,2022,35(04):36.[doi:10.3969/j.issn.1006-1959.2022.15.007]
[2]刘 彻,艾力·赛丁,苏鹏程.甲状腺乳头状癌颈部淋巴结转移特点及相关危险因素分析[J].医学信息,2019,32(23):70.[doi:10.3969/j.issn.1006-1959.2019.23.019]
　LIU Che,Aili·SaiDing,SU Peng-cheng.Analysis of Cervical Lymph Node Metastasis and Related Risk Factors in Papillary Thyroid Carcinoma[J].Medical Information,2019,32(04):70.[doi:10.3969/j.issn.1006-1959.2019.23.019]
[3]唐嘉晨,郝玲玲,秦晓茹,等.全腔镜下甲状腺乳头状癌并发症Meta分析[J].医学信息,2021,34(04):78.[doi:10.3969/j.issn.1006-1959.2021.04.021]
　TANG Jia-chen,HAO Ling-ling,QIN Xiao-ru,et al.Meta-analysis of Complications of Papillary Thyroid Carcinoma Under Full Laparoscopic Surgery[J].Medical Information,2021,34(04):78.[doi:10.3969/j.issn.1006-1959.2021.04.021]
[4]范雪峰,王伦锋,余招焱,等.左侧及右侧中央区淋巴结清扫在甲状腺乳头状癌术中的应用[J].医学信息,2021,34(09):5.[doi:10.3969/j.issn.1006-1959.2021.09.002]
　FAN Xue-feng,WANG Lun-feng,YU Zhao-yan,et al.Left and Right Central Lymph Node Dissection in the Operation of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(04):5.[doi:10.3969/j.issn.1006-1959.2021.09.002]
[5]徐海燕,潘景润,宫希军,等.CT增强联合甲状腺球蛋白及抗体在甲状腺乳头状癌颈部淋巴结转移中的预测价值[J].医学信息,2021,34(20):119.[doi:10.3969/j.issn.1006-1959.2021.20.030]
　XU Hai-yan,PAN Jing-run,GONG Xi-jun,et al.The Value of CT Enhancement Combined with Thyroglobulin and Antibody in PredictingCervical Lymph Node Metastasis of Papillary Thyroid Carcinoma[J].Medical Information,2021,34(04):119.[doi:10.3969/j.issn.1006-1959.2021.20.030]
[6]李佳楠,陈春悠.STAT3、NCK1和VEGF在甲状腺乳头状癌中的表达及临床意义[J].医学信息,2022,35(05):94.[doi:10.3969/j.issn.1006-1959.2022.05.023]
　LI Jia-nan,CHEN Chun-you.Expression of STAT3, NCK1 and VEGF in Papillary Thyroid Carcinoma and its Clinical Significance[J].Medical Information,2022,35(04):94.[doi:10.3969/j.issn.1006-1959.2022.05.023]
[7]李雪松,苏新良,陶冬梅.术前诊断不明确的甲状腺乳头状癌的风险分析[J].医学信息,2024,37(04):119.[doi:10.3969/j.issn.1006-1959.2024.04.021]
　LI Xue-song,SU Xin-liang,TAO Dong-mei.Risk Analysis of Papillary Thyroid Carcinoma with Undefinable Preoperative Diagnosis[J].Medical Information,2024,37(04):119.[doi:10.3969/j.issn.1006-1959.2024.04.021]

更新日期/Last Update: 1900-01-01